Abstract
Report Description
The global market for neurostimulation products is expected to be worth $3.6
billion in 2009, growing at a CAGR of 22.7%, driven by the multiple treatment
applications of neurostimulation products, and the emergence of venture
capital in the industry. Neurostimulation is used for the treatment of several
debilitating conditions, including major treatment-resistant depression,
epilepsy, gastroparesis, hearing loss, incontinence, chronic pain, Parkinson' s
disease, and essential tremors. Neurostimulation systems provide an improved
lifestyle alternative to many patients who do not obtain relief from standard
drug and invasive surgical therapy.
The neurostimulation market is driven mainly by technology advancements,
rising consumer awareness, rising age-related neurological disorders, improved
clinical outcomes, long-term cost-effectiveness, increased FDA approvals for
clinical trials, and the development of sophisticated implantable
neurostimulation devices. Currently, there is a huge influx of new players
entering into the market, thus leading to increased investments and R&D
activities.
Implantable neurostimulation devices are increasingly being used for the
treatment of a number of chronic disorders such as pain management and
epilepsy. Manufacturers are employing developments in low-power semiconductor
design, improved manufacturing procedures, and longer battery life for such
devices to offer effective, efficient, and long-lasting neurostimulation
products. Innovative products such as closed-loop system neurostimulator are
designed to continuously stimulate the nervous system.
SCOPE AND FORMAT
The report analyzes the global biomarker market into the following segments:
- Product Market (spinal cord stimulator, deep brain stimulator, vagus
nerve stimulator, sacral nerve stimulator, and gastric electrical stimulator )
- Application Market (Alzheimer' s, Parkinson' s, chronic heart failure,
essential tremors, eye disorders, paralysis, obesity, and other medical
conditions )
- Technology Market (minimally-invasive and non-invasive stimulation
technology )
The market data consists of aggregate sales figures of all neurostimulation
submarkets. It analyzes the market aspects of new neurostimulation
technologies and product launches; sourcing key market developments from the
top companies that it profiles. The report also analyzes the documented claims
and the neurostimulation technology patents approved over the last five years
to provide an in-depth understanding of neurostimulation product and
applications.
What makes our report unique?
The existing studies and third-party market reports do not provide a
comprehensive understanding of the neurostimulation market. The critical
markets within this broader field are also not analyzed. This report gives a
detailed analysis of the overall market as well as its most critical
micro-markets, which have so far remained unexplored. In addition to the
comprehensive information on the macro-markets, the report provides market
data for up to five levels of the micro-markets under these identified macro
markets. Other reports cover only the major technologies or products; and miss
out subsequent micro levels.
Key questions answered
- Which are the high growth markets segments in terms of products,
applications, and technology?
- What are the market forecasts and estimates from the period 2009-14?
- What are the major drivers and opportunities in the market?
| 
View Cart
